RecruitingNot ApplicableNCT06311435

Utilizing Novel Blood RNA Biomarkers as a Diagnostic Tool in the Identification of Long COVID-19

Sponsor

MaxWell Clinic, PLC

Enrollment

224 participants

Start Date

Mar 15, 2024

Study Type

INTERVENTIONAL

Conditions

Long COVID

Summary

The Primary objective of this study is to determine, using unblinded samples, if it is possible to develop an algorithm for the classification of specific blood RNA from patients with long COVID together and separately from the apparent health normal controls and other medical conditions that share the signs and symptoms of long COVID.

Eligibility

Min Age: 18 Years

Inclusion Criteria3

Mentally capable of understanding and completing informed consent for the study.
Precipitants with a lab verified diagnosis of SARS-CoV-2 or clinician note/record that an appropriate rapid test for SARS-CoV-2 was positive.
To qualify for long COVID group participants will need to have new, persistent symptoms related to SARS-CoV-2 infection. iv. No one under the age of 18.

Exclusion Criteria2

Subject is unable to provide informed consent.
Primary Investigator or Sub-Investigator determines the participant's ongoing medical complaints that began after 1 November 2019 are not related to SARS-COV-2 but another disease process.

Interested in this trial?

Get notified about updates and connect with the research team.